Molecular diagnostic kit for identifying genetic variations affecting drug metabolism in cardiovascular disease patients. Provides guidance for personalized medication selection in heart disease management.
Manufactured by
Wuhan YZY Medical Science and Technology Co.,Ltd.
China
YZY Medical is a high-tech enterprise specializing in personalized molecular diagnostics for cardiovascular and oncology applications. The company has developed 160+ genetic diagnostic products and multiple IVD devices, with 14 molecular diagnostic kits holding NMPA Class III registration. Technical platforms include ARMS qPCR, multiplex qPCR, mass spectrometry, FISH, and circulating tumor cell detection. The company operates a 2,000 sqm R&D center and 3,200 sqm GMP production facility with ISO13485:2016 and CE certifications.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Xi'an Tianlong Science And Technology Co., Ltd
China · 1 relevant product
GENERI BIOTECH s.r.o.
Czech Republic · 9 relevant products
HymonBio Co., Ltd.
China · 3 relevant products
61 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →15 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 104 closest product alternatives
Xi'an Tianlong Science And Technology Co., Ltd · China
Genetic testing kit for analyzing drug metabolism genes and predicting medication response. Supports personalized medicine and optimized drug dosing based on genetic profiles.
GENERI BIOTECH s.r.o. · Czech Republic
CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.
HymonBio Co., Ltd. · China
In vitro diagnostic kit for detecting metabolic enzyme gene polymorphisms to assess individual drug metabolism capacity and guide personalized medication therapy. Uses molecular analysis to identify genetic variants affecting cytochrome P450 and other metabolic enzymes, enabling clinicians to optimize drug selection and dosing based on patient pharmacogenetic profiles.
101 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products